UBS Raises Alignment Healthcare PT to $21 on Strong Membership Growth, 2026 EBITDA Outlook

Alignment Healthcare Inc. (NASDAQ:ALHC) is one of the best mid-cap growth stocks to buy right now. On January 14, UBS raised its price target on Alignment Healthcare to $21 from $18, while maintaining a Neutral rating. On January 6, Piper Sandler analyst Jessica Tassan raised the firm’s price target for Alignment Healthcare Inc. (NASDAQ:ALHC) from $20 to $30 and maintained an Overweight rating. The firm updated its financial model to account for strong Annual Enrollment Period/AEP sales and retention leve ...